L. Willems

CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD).

E. Adang, V. Deneer, C. Kramers, 2022, American heart journal.

A protocol for DUAL pathway inhibition (low-dose rivaroxaban and aspirin) as compared to aspirin only to improve endothelial function in peripheral artery disease

M. Warlé, L.H. Willems, D. Thijssen, 2021, Medicine: Case Reports and Study Protocols.

Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19

M. Netea, D. Thijssen, G. Hannink, 2021, Thrombosis Research.